Abstract
Lasers and light-emitting devices have now taken a key role in the treatment of vitiligo and hypomelanosis. Q-switched depigmenting lasers can be used to treat the residual pigmented spots in the generalized forms of vitiligo. Ablative lasers bring a rapid and reproductive tool to prepare the grafting bed for the segmental and localized forms of vitiligo or for inherited hypochromic disorders such as piebaldism. The 308-nm excimer lasers and lamps are clearly the devices that brought the more progresses for taking in charge hypochromic disorders. With higher rates of repigmentation as compared to conventional phototherapy and with a specific targeting of the lesions sparing the surrounding skin, their main limitation remains the surface to treat. Finally, new wavelengths will certainly be used in the near future to enhance repigmentation. The 632.8-nm helium–neon laser has already brought encouraging results that are worthy of further study.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Anbar TS, Westerhof W, Abdel-Rahman AT, Ewis AA, El-Khayyat MA. Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study. Photodermatol Photoimmunol Photomed. 2008;24:322–9.
Baltas E, Csoma Z, Ignacz F, Dobozy A, Kemeny L. Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch Dermatol. 2002;138:1619–20.
Bonis B, Kemeny L, Dobozy A, Bor Z, Szabo G, Ignacz F. 308 nm UVB excimer laser for psoriasis. Lancet. 1997;350:1522.
Casacci M, Thomas P, Pacifico A, Bonnevalle A, Paro Vidolin A, Leone G. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311–313 nm) in the treatment of vitiligo–a multicentre controlled study. J Eur Acad Dermatol Venereol. 2007;21:956–63.
Chilbert MA, Peak MJ, Peak JG, Pellin MJ, Gruen DM, Williams GA. Effects of intensity and fluence upon DNA single-strand breaks induced by excimer laser radiation. Photochem Photobiol. 1988;47:523–5.
Choi KH, Park JH, Ro YS. Treatment of vitiligo with 308-nm xenon-chloride excimer laser: therapeutic efficacy of different initial doses according to treatment areas. J Dermatol. 2004;31:284–92.
de With A, Greulich KO. Wavelength dependence of laser-induced DNA damage in lymphocytes observed by single-cell gel electrophoresis. J Photochem Photobiol B. 1995;30:71–6.
Esposito M, Soda R, Costanzo A, Chimenti S. Treatment of vitiligo with the 308 nm excimer laser. Clin Exp Dermatol. 2004;29:133–7.
Falabella R. Surgical approaches for stable vitiligo. Dermatol Surg. 2005;31:1277–84.
Falabella R, Barona MI. Update on skin repigmentation therapies in vitiligo. Pigment Cell Melanoma Res. 2009;22:42–65.
Friedman PM, Geronemus RG. Use of the 308-nm excimer laser for postresurfacing leukoderma. Arch Dermatol. 2001;137:824–5.
Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, et al. Guideline for the diagnosis and management of vitiligo. Br J Dermatol. 2008;159:1051–76.
Goldberg DJ, Sarradet D, Hussain M. 308-nm excimer laser treatment of mature hypopigmented striae. Dermatol Surg. 2003;29:596–8; discussion 598–9.
Goldinger SM, Dummer R, Schmid P, Burg G, Seifert B, Lauchli S. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo. J Eur Acad Dermatol Venereol. 2007;21:504–8.
Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol. 2002;47:789–91.
Guerra L, Primavera G, Raskovic D, Pellegrini G, Golisano O, Bondanza S, et al. Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. Arch Dermatol. 2003;139:1303–10.
Guerra L, Primavera G, Raskovic D, Pellegrini G, Golisano O, Bondanza S, et al. Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis. Br J Dermatol. 2004;150:715–21.
Gundogan C, Greve B, Hausser I, Raulin C. [Repigmentation of persistent laser-induced hypopigmentation with an excimer laser following tattoo removal]. Hautarzt 2004;55:549–52.
Hofer A, Hassan AS, Legat FJ, Kerl H, Wolf P. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. Br J Dermatol. 2005;152:981–5.
Hofer A, Hassan AS, Legat FJ, Kerl H, Wolf P. The efficacy of excimer laser (308 nm) for vitiligo at different body sites. J Eur Acad Dermatol Venereol. 2006;20:558–64.
Hong SB, Park HH, Lee MH. Short-term effects of 308–nm xenon-chloride excimer laser and narrow-band ultraviolet b in the treatment of vitiligo: a Comparative Study. J Korean Med Sci. 2005;20:273–8.
Hu WP, Wang JJ, Yu CL, Lan CC, Chen GS, Yu HS. Helium-neon laser irradiation stimulates cell proliferation through photostimulatory effects in mitochondria. J Invest Dermatol. 2007;127:2048–57.
Kahn AM, Ostad A, Moy RL. Grafting following short-pulse carbon dioxide laser de-epithelialization. Dermatol Surg. 1996;22:965–7; discussion 967–8
Kawalek AZ, Spencer JM, Phelps RG. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg. 2004;30:130–5.
Kim do Y, Lee K, Park YK. Use of the 308-nm excimer laser for nevus depigmentosus: a promising treatment for either nevus depigmentosus or vitiligo. J Dermatol. 2007;34:217–8.
Kim YJ, Chung BS, Choi KC. Depigmentation therapy with Q-switched ruby laser after tanning in vitiligo universalis. Dermatol Surg. 2001;27:969–70.
Lan C, Wu C, Chen G, Yu H. Helium-neon laser and topical tacrolimus combination therapy: novel treatment option for vitiligo without additional photocarcinogenic risks. J Eur Acad Dermatol Venereol. 2008;23:344–5.
Lan CC, Wu CS, Chiou MH, Hsieh PC, Yu HS. Low-energy helium-neon laser induces locomotion of the immature melanoblasts and promotes melanogenesis of the more differentiated melanoblasts: recapitulation of vitiligo repigmentation in vitro. J Invest Dermatol. 2006;126:2119–26.
Le Duff F, Fontas E, Giacchero D, Sillard L, Lacour JP, Ortonne JP, Passeron T. 308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study. Br J Dermatol. 2010;163(1):188-92.
Leone G, Iacovelli P, Paro Vidolin A, Picardo M. Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study. J Eur Acad Dermatol Venereol. 2003;17:531–7.
Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003;139:581–5.
Mulekar SV, Issa AA, Eisa AA. Treatment of halo nevus with a 308-nm excimer laser: a pilot study. J Cosmet Laser Ther. 2007;9:245–8.
Njoo MD, Vodegel RM, Westerhof W. Depigmentation therapy in vitiligo universalis with topical 4–methoxyphenol and the Q-switched ruby laser. J Am Acad Dermatol. 2000;42:760–9.
Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP. The pigmentary system: physiology and pathophysiology. Edinburgh: Blackwell Science; 2006.
Oh CK, Cha JH, Lim JY, Jo JH, Kim SJ, Jang HS, et al. Treatment of vitiligo with suction epidermal grafting by the use of an ultrapulse CO2 laser with a computerized pattern generator. Dermatol Surg. 2001;27:565–8.
Ortonne JP. Vitiligo and other disorders of hypopigmentation. In: Bolognia J, Jorizzo JL, Rapini RP, editors. Dermatolgy. New York: Mosby; 2007. p. 913–38.
Ortonne JP, Passeron T. Melanin pigmentary disorders: treatment update. Dermatol Clin. 2005;23:209–26.
Ostovari N, Passeron T, Lacour JP, Ortonne JP. Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure. Arch Dermatol. 2006;142:252–3.
Ostovari N, Passeron T, Zakaria W, Fontas E, Larouy JC, Blot JF, et al. Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response. Lasers Surg Med. 2004;35:152–6.
Pai GS, Vinod V, Joshi A. Efficacy of erbium YAG laser-assisted autologous epidermal grafting in vitiligo. J Eur Acad Dermatol Venereol. 2002;16:604–6.
Passeron T, Mantoux F, Ortonne JP. Genetic disorders of pigmentation. Clin Dermatol. 2005;23:56–67.
Passeron T, Ostovari N, Zakaria W, Fontas E, Larrouy JC, Lacour JP, et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol. 2004;140:1065–9.
Rao J, Fitzpatrick RE. Use of the Q-switched 755-nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo. Dermatol Surg. 2004;30:1043–5.
Sassi F, Cazzaniga S, Tessari G, Chatenoud L, Reseghetti A, Marchesi L, et al. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck. Br J Dermatol. 2008;159:1186–91.
Smith DA, Tofte SJ, Hanifin JM. Repigmentation of vitiligo with topical tacrolimus. Dermatology (Basel, Switzerland) 2002;205:301–3.
Spencer JM, Nossa R, Ajmeri J. Treatment of vitiligo with the 308–nm excimer laser: a pilot study. J Am Acad Dermatol. 2002;46:727–31.
Taneja A, Trehan M, Taylor CR. 308-nm excimer laser for the treatment of localized vitiligo. Int J Dermatol. 2003;42:658–62.
Tanghetti EA. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series. Cutis. 2003;71:158–62.
Travis LB, Weinberg JM, Silverberg NB. Successful treatment of vitiligo with 0.1% tacrolimus ointment. Arch Dermatol. 2003;139:571–4; discussion 573.
van Geel N, Ongenae K, Naeyaert JM. Surgical techniques for vitiligo: a review. Dermatology (Basel, Switzerland) 2002;202:162–6.
Westerhof W, Nieuweboer-Krobotova L, Mulder PG, Glazenburg EJ. Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo. Arch Dermatol. 1999;135:1061–6.
Whitton ME, Ashcroft DM, Gonzalez U. Therapeutic interventions for vitiligo. J Am Acad Dermatol. 2008;59:713–7.
Yu HS, Wu CS, Yu CL, Kao YH, Chiou MH. Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo. J Invest Dermatol. 2003;120:56–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Passeron, T., Ortonne, JP. (2011). Pigmentation and Hypopigmentation: Vitiligo and Other Disorders. In: Raulin, C., Karsai, S. (eds) Laser and IPL Technology in Dermatology and Aesthetic Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03438-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-03438-1_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-03437-4
Online ISBN: 978-3-642-03438-1
eBook Packages: MedicineMedicine (R0)